β-Blockers, heart disease and COPD: current controversies and uncertainties

JG Baker, RG Wilcox - Thorax, 2017 - thorax.bmj.com
Treating people with cardiovascular disease and COPD causes significant clinician anxiety.
β-Blockers save lives in people with heart disease, specifically postinfarction and heart …
被引用次数：86 相关文章

β-Blockers, heart disease and COPD: current controversies and uncertainties.

JG Baker, RG Wilcox - Thorax, 2016 - europepmc.org
Treating people with cardiovascular disease and COPD causes significant clinician anxiety.
β-Blockers save lives in people with heart disease, specifically postinfarction and heart …

[beta]-Blockers, heart disease and COPD: current controversies and uncertainties

JG Baker, RG Wilcox - Thorax, 2017 - search.proquest.com
Treating people with cardiovascular disease and COPD causes significant clinician anxiety.
β-Blockers save lives in people with heart disease, specifically postinfarction and heart …

β-Blockers, heart disease and COPD: current controversies and uncertainties

JG Baker, RG Wilcox - Thorax, 2016 - thorax.bmj.com
Treating people with cardiovascular disease and COPD causes significant clinician anxiety.
β-Blockers save lives in people with heart disease, specifically postinfarction and heart …

β-Blockers, heart disease and COPD: current controversies and uncertainties

JG Baker, RG Wilcox - Thorax, 2017 - pubmed.ncbi.nlm.nih.gov
Treating people with cardiovascular disease and COPD causes significant clinician anxiety.
β-Blockers save lives in people with heart disease, specifically postinfarction and heart …

[引用][C] β-Blockers, heart disease and COPD: current controversies and uncertainties

JG Baker, RG Wilcox - Thorax, 2016 - cir.nii.ac.jp
β-Blockers, heart disease and COPD: current controversies and uncertainties | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文 …